157 related articles for article (PubMed ID: 12849539)
1. Susceptibility testing for Alzheimer's disease: race for the future.
Barber M; Whitehouse PJ
Lancet Neurol; 2002 May; 1(1):10. PubMed ID: 12849539
[No Abstract] [Full Text] [Related]
2. The APOE-epsilon4 allele and Alzheimer disease among African Americans, Hispanics, and whites.
Farkas BL
JAMA; 1998 Nov; 280(19):1662; author reply 1663. PubMed ID: 9831993
[No Abstract] [Full Text] [Related]
3. The APOE-epsilon4 allele and Alzheimer disease among African Americans, Hispanics, and whites.
Barker W; Harwood D; Duara R; Mullan M; Fallin D; Hyslop PS; Rogaeva E; Song Y
JAMA; 1998 Nov; 280(19):1661-2; author reply 1663. PubMed ID: 9831992
[No Abstract] [Full Text] [Related]
4. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease.
Desai P; DeKosky ST; Kamboh MI
Neurosci Lett; 2002 Aug; 328(1):9-12. PubMed ID: 12123847
[TBL] [Abstract][Full Text] [Related]
5. Risk of dementia among white and African American relatives of patients with Alzheimer disease.
Green RC; Cupples LA; Go R; Benke KS; Edeki T; Griffith PA; Williams M; Hipps Y; Graff-Radford N; Bachman D; Farrer LA;
JAMA; 2002 Jan; 287(3):329-36. PubMed ID: 11790212
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E, Alzheimer disease, and African Americans.
Mayeux R
Arch Neurol; 2003 Feb; 60(2):161-3. PubMed ID: 12580698
[No Abstract] [Full Text] [Related]
7. Apolipoprotein E and age at onset of Alzheimer's disease in African American patients.
Goldstein FC; Ashley AV; Gearing M; Hanfelt J; Penix L; Freedman LJ; Levey AI
Neurology; 2001 Nov; 57(10):1923-5. PubMed ID: 11723294
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E4 and tau allele frequencies among Choctaw Indians.
Henderson JN; Crook R; Crook J; Hardy J; Onstead L; Carson-Henderson L; Mayer P; Parker B; Petersen R; Williams B
Neurosci Lett; 2002 May; 324(1):77-9. PubMed ID: 11983299
[TBL] [Abstract][Full Text] [Related]
9. The APOE-epsilon4 allele and Alzheimer disease among African Americans, Hispanics, and whites.
Grant WB
JAMA; 1998 Nov; 280(19):1662-3; author reply 1663. PubMed ID: 9831994
[No Abstract] [Full Text] [Related]
10. The APOE-epsilon4 allele and Alzheimer disease among African Americans, Hispanics, and whites.
Méndez HA
JAMA; 1998 Nov; 280(19):1663. PubMed ID: 9831995
[No Abstract] [Full Text] [Related]
11. Effects of age and ethnicity on the link between APOE epsilon4 and Alzheimer disease.
Shadlen MF
JAMA; 1998 Feb; 279(8):581; author reply 581-2. PubMed ID: 9486747
[No Abstract] [Full Text] [Related]
12. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status.
Evans DA; Bennett DA; Wilson RS; Bienias JL; Morris MC; Scherr PA; Hebert LE; Aggarwal N; Beckett LA; Joglekar R; Berry-Kravis E; Schneider J
Arch Neurol; 2003 Feb; 60(2):185-9. PubMed ID: 12580702
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein-E epsilon 4 allele frequency and conferred risk for Cuban Americans with Alzheimer's disease.
Sevush S; Peruyera G; Crawford F; Mullan M
Am J Geriatr Psychiatry; 2000; 8(3):254-6. PubMed ID: 10910426
[TBL] [Abstract][Full Text] [Related]
14. The very low density lipoprotein (VLDL) receptor is a genetic susceptibility factor for Alzheimer disease in a European Caucasian population.
Helbecque N; Richard F; Cottel D; Neuman E; Guez D; Amouyel P
Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):368-71. PubMed ID: 9876967
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.
Pedraza O; Allen M; Jennette K; Carrasquillo M; Crook J; Serie D; Pankratz VS; Palusak R; Nguyen T; Malphrus K; Ma L; Bisceglio G; Roberts RO; Lucas JA; Ivnik RJ; Smith GE; Graff-Radford NR; Petersen RC; Younkin SG; Ertekin-Taner N
Alzheimers Dement; 2014 Mar; 10(2):205-13. PubMed ID: 23643458
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E and the neuropathology of Alzheimer's disease.
Mirra SS
Hum Pathol; 1999 Oct; 30(10):1125-7. PubMed ID: 10534156
[No Abstract] [Full Text] [Related]
17. APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.
Hendrie HC; Murrell J; Baiyewu O; Lane KA; Purnell C; Ogunniyi A; Unverzagt FW; Hall K; Callahan CM; Saykin AJ; Gureje O; Hake A; Foroud T; Gao S
Int Psychogeriatr; 2014 Jun; 26(6):977-85. PubMed ID: 24565289
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Alzheimer's disease risk factors in white and African American families.
Bachman DL; Green RC; Benke KS; Cupples LA; Farrer LA;
Neurology; 2003 Apr; 60(8):1372-4. PubMed ID: 12707449
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks.
Maestre G; Ottman R; Stern Y; Gurland B; Chun M; Tang MX; Shelanski M; Tycko B; Mayeux R
Ann Neurol; 1995 Feb; 37(2):254-9. PubMed ID: 7847867
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans.
Hendrie HC; Hall KS; Hui S; Unverzagt FW; Yu CE; Lahiri DK; Sahota A; Farlow M; Musick B; Class CA
Ann Neurol; 1995 Jan; 37(1):118-20. PubMed ID: 7818244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
